Research institute in
Baar

93 companies in Research institute based in Baar — name and year of registration from the commercial register.

Companies

50 of 93 companies

3 D AG

Since 1989 · 11–20 empl.5.0(6)

3 D AG provides micro- and nanotechnology development and manufacturing services, including master templates, nickel shims, electroforming, UV imprinting and replication for industrial application. The company also supplies brand- and product-protection solutions such as hologram labels, smart labels, NFC integration and digitalization/blockchain services for security and serialization use cases.

Research instituteMicro & Nano LabBrandbuilding & SecurityProducts & Solutions

Biogen Switzerland AG

Since 1996 · 51–100 empl.

The core activity of Biogen is the research, development and production of medicines, in particular large and small molecular therapeutics, as well as biosimilars, with a focus on the treatment of severe diseases such as neurology, neuropsychiatry, immunology and rare diseases.

Research instituteMedicinesClinical TrialsPipeline

Limmat Scientific AG

Since 2005 · 1–10 empl.

The core activity of Limmat Scientific is the development and provision of engineering services and measurement technologies for the aerospace, power generation, automotive, medical and process engineering industries. In particular, the company focuses on the development of precise and fast aerodynamic probe measurement technologies, including the manufacture of five-hole probes, FRAP probes (Fast-Response Aerodynamic Probes) and wireless measurement systems.

Research instituteFast-Response Aerodynamic Probes (FRAP)Fast-pressure sensorsTurn-key measurement systems

Sanoviva AG

Since 2007 · 11–20 empl.

The core activity of SanoViva is the development and research of sustainable products and technologies for the health of soils, plants, animals and humans. This includes the development of recipes and products from natural, organic and mineral raw materials, as well as the granting of licenses for the marketing of these products to partner companies.

Research instituteNo identifiable offerings

Alexion Pharma GmbH

Since 2007 · 21–50 empl.

The core activity of Alexion is the development and provision of life-changing therapies for people with rare diseases. The company focuses on researching, developing and delivering medicines tailored to the needs of patients with rare diseases, and strives to improve the quality of life of these individuals.

Research instituteMedicines for rare diseasesResearch and development for rare diseasesPatient support programmes

1abtik ag

Since 2015 · 1–10 empl.

The core activity of 1abtik is the application of bio-chemical molecules for health purposes, particularly through the provision of knowledge and networking in the field of Life Sciences.

Management consultantDrug developmentStrategic company and business development

Helvatron AG

Since 2015 · 11–20 empl.

The core activity of Helvatron AG is the development and provision of energy management software and hardware for measuring, monitoring and optimizing energy consumption. The company offers a comprehensive range of products and services, including intelligent energy meters, energy measuring devices, automation solutions and web-based software for evaluating and visualizing energy consumption data. The solutions are designed to support companies in the sustainable use of electrical energy and improve energy efficiency.

Research instituteISO 50001 energy managementM-Bus Central | M-Bus data loggerThree-phase energy meters

BIONOVATICS AG

Since 2016 · 1–10 empl.

BIONOVATICS AG develops microbiological preparations for plant protection and nutrition. The company operates research and development laboratories and production facilities and supplies biological fungicides, bioinsecticides, microbial fertilizers and plant growth regulators.

Research instituteBiological crop protection productsBiological fertilisersAnti-stress formulations

KEYONIQ Health AG

Since 2016 · 1–10 empl.

KEYONIQ Health AG develops personalised health analytics and services that translate clinical and biomarker data into evidence-based action plans for healthier, longer lives. The company combines research, clinical expertise, large biomarker datasets and AI (InsightQore™; Biological Age Clock) to provide tailored recommendations on medications, supplements, nutrition, exercise, wellbeing and treatments.

Research instituteHealth analysis and personalized action plansBiological Age ClockLongevity and Healthspan consulting

Extrovis AG

Since 2016 · 101–500 empl.

Extrovis AG is a global Contract Research, Development & Manufacturing Organization (CRDMO) that develops and manufactures complex specialty therapeutics, including sterile antibiotics, oncology and cytotoxic formulations, and female hormone products. The company provides R&D, regulated-market manufacturing (USFDA, EU‑GMP) and supply‑chain and regulatory support across drug substances and finished dosage forms.

Research instituteAPI manufacturingPharmaceutical manufacturingResearch and Development

Apellis International GmbH

Since 2019 · 11–20 empl.

Apellis International GmbH develops medicines that inhibit the complement cascade by targeting the central protein C3. Its products include the C3‑targeting medicines EMPAVELI® and SYFOVRE®, and the company advances clinical and preclinical programs across ophthalmology, hematology, nephrology and gene-/RNA‑based therapeutic approaches.

Research instituteTherapeuticsClinical trialsResearch and drug development

Centenara Labs AG

Since 2019 · 11–20 empl.

The core activity of Centenara Labs AG is the development and investment in therapies that combat age-related diseases such as cancer, muscle weakness, vision loss, and cognitive impairments. The company focuses on researching and developing medications that address the so-called "Hallmarks of Aging" to improve the health and well-being of older people and extend their lifespan.

Research instituteDevelopment and investment in therapies for age-related diseasesDevelopment of senescence therapeuticsDevelopment of telomer therapeutics

Apellis Schweiz GmbH

Since 2023 · 21–50 empl.

Apellis Schweiz GmbH is a biopharmaceutical company that develops medicines that inhibit the complement cascade, with a particular focus on the complement protein C3. Its pipeline and approved products target conditions such as geographic atrophy, C3 glomerulopathy/primary immune complex‑mediated membranoproliferative glomerulonephritis, and paroxysmal nocturnal hemoglobinuria, and the site cites products including Empaveli and Syfovre.

Research instituteDrug therapies for rare diseases and geographic atrophyPatient and caregiver information

PLIM Group AG

Since 1996 · 1–10 empl.

PLIM Group AG is a company focused on technology and people. The website does not provide further details about its products or services and currently shows a coming-soon page.

Research institute inBaar

50 of 93 companies

Research institute in the region

Research institute in other places

Other industries in Baar

Research institute in
Baar